Market Place
Sourcing Support
All News #Library
Others
Serina Therapeutics To Present At 5th LNP Formulation Summit
07 Apr 2026 //
GLOBENEWSWIRE
Serina Therapeutics Gets NYSE American Continued Listing Approval
02 Apr 2026 //
GLOBENEWSWIRE
Serina Pharma Secures Up to $30M for Adv. PD Registrational Trial
18 Mar 2026 //
GLOBENEWSWIRE
Tribe Public CEO Hosts Webinar For Presentation And Q&A Event
03 Feb 2026 //
GLOBENEWSWIRE
Serina Therapeutics Q2 2025 Financial Results and Highlights
11 Aug 2025 //
GLOBENEWSWIRE
Serina Therapeutics Develops POZ-VMAT2i for Tardive Dyskinesia
29 Jul 2025 //
GLOBENEWSWIRE
Tribe Public CEO Presentation & Q&A Webinar
09 Jun 2025 //
GLOBENEWSWIRE
Serina Therapeutics Appoints Stephen Brannan, M.D. to Board
22 May 2025 //
GLOBENEWSWIRE
Serina Therapeutics Reports Q1 2025 Financial Results & Highlight
08 May 2025 //
GLOBENEWSWIRE
Serina Therapeutics Appoints Srini Tenjarla As SVP Of CMC And Formulation
18 Jul 2024 //
GLOBENEWSWIRE
Enable, Serina Announce SER-252 + enFuse Agreement For Parkinson`s
15 May 2024 //
GLOBENEWSWIRE
Serina Therapeutics Reports Q1 2024 Results, Business Highlights
14 May 2024 //
GLOBENEWSWIRE
Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman
17 Apr 2024 //
GLOBENEWSWIRE
Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics
26 Mar 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.